AKT1 and neoplasm: Song et al. showed that PIM kinase can induce tumor cell resistance to inhibitors of PI3K/AKT signaling by increasing nuclear factor E2-related factor 2 (NRF2) levels and stimulating the production of ROS scavengers [56].